Jasper Therapeutics Inc. (JSPRW) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Jasper Therapeutics Inc.

NASDAQ: JSPRW · Real-Time Price · USD
0.09
-0.01 (-14.29%)
At close: Jun 09, 2025, 3:57 PM

Jasper Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.17M 1.17M 2.05M 2.05M 2.05M 2.05M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
886K 1.17M 870K 1.15M 1.22M 1.31M 1.39M 1.48M 1.41M 1.31M 1.17M 1.15M 838K 566K 336K n/a n/a
Gross Profit
288K n/a 1.18M 906K 828K 743K -1.39M -1.48M -1.41M -1.31M -1.17M -1.15M -838K -566K -336K n/a n/a
Operating Income
-82.97M -76.24M -68.68M -68.15M -69.99M -68.86M -64.88M -58.23M -52.37M -51.2M -49.53M -46.9M -43.36M -36.83M -30.71M -26.64M -24.23M
Interest Income
4.3M 5.06M 5.35M 5.5M 5.49M 5.2M 3.96M 2.8M 1.36M 268K 268K n/a n/a n/a n/a n/a n/a
Pretax Income
13.73M n/a -63.53M -62.44M -63.93M -64.47M -61.09M -55.41M -49.74M -37.69M -33.53M -25.08M -23.09M -30.64M -31.57M -38.98M -39.99M
Net Income
13.73M n/a -63.53M -62.44M -63.93M -66.12M -62.21M -55.42M -48.18M -23.91M -20.29M -12.95M -12.52M -30.64M -31.57M -38.98M -39.99M
Selling & General & Admin
21.58M 20.42M 18.22M 17.3M 17.14M 16.79M 17.65M 16.82M 16.12M 16.57M 15.53M 14.73M 14.17M 11.41M 9.3M 7.89M 5.87M
Research & Development
61.68M 55.82M 49.88M 50.28M 52.28M 51.78M 47.23M 41.41M 36.24M 34.63M 34M 32.17M 29.19M 25.42M 21.41M 18.74M 18.36M
Other Expenses
22K n/a -180K -129K -198K -246K 173K 122K 320K 318K 17K 17K -68K 5K 5K 5K 1K
Operating Expenses
83.26M 76.24M 68.11M 67.58M 69.42M 68.58M 64.88M 58.23M 52.37M 51.2M 49.53M 46.9M 43.36M 36.83M 30.71M 26.64M 27.61M
Interest Expense
5.06M 5.06M n/a n/a n/a 313K 313K 581K 581K 268K 268K 9K 9K 3.51M 7.54M 7.64M 7.64M
Selling & Marketing Expenses
288K n/a -571K -571K -571K -283K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
62.04M 77.11M 68.68M 68.15M 69.99M 68.86M 64.88M 58.23M 52.37M 51.2M 49.53M 46.9M 43.36M 36.83M 30.71M 26.64M 27.61M
Income Tax Expense
-244.72K n/a 1.86M 149.72K -1.41M n/a -2.45M -1.85M -1.56M -13.78M -22.54M -21.56M -20.01M -2.44M 10.89M 15.73M 15.74M
Shares Outstanding (Basic)
14.58M 14.58M 15M 14.99M 13.33M 11.04M 10.97M 10.92M 8.82M 3.67M 36.57M 36.4M 36.31M 4.97M 4.97M 37.82M 37.82M
Shares Outstanding (Diluted)
14.58M 14.58M 15M 14.99M 13.33M 11.04M 10.97M 10.92M 8.82M 3.67M 36.57M 36.4M 36.31M 4.97M 4.97M 37.82M 37.82M
EPS (Basic)
-0.4 -0.02 -4.74 -5.1 -5.6 -6.37 -8.33 -7.02 -5.79 -3.76 -2.12 -2.52 -2.5 -2.99 -1.43 -1.03 -16.89
EPS (Diluted)
-0.4 -0.02 -4.74 -5.1 -5.6 -6.37 -8.33 -7.02 -5.79 -3.76 -2.12 -2.52 -2.5 -2.99 -1.43 -1.03 -16.87
EBITDA
-10.97M -3.95M -67.27M -67.01M -68.86M -67.75M -63.78M -57.14M -51.33M -50.22M -48.63M -39.26M -35.91M -29.58M -17.78M -20.72M -12.33M
EBIT
15.07M n/a -68.68M -68.15M -69.99M -68.86M -64.88M -58.23M -52.37M -51.2M -52.71M -43.4M -39.86M -33.33M -24.12M -31.43M -29.03M
Depreciation & Amortization
-288K n/a 1.41M 1.15M 1.22M 1.31M 1.39M 1.48M 1.41M 1.31M 1.17M 1.15M 867K 617K 6.34M 12.02M 18M